Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2, 2002
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- BRCA1 Protein (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Clinical Trials as Topic (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Mutation (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Receptors, Estrogen (MeSH)
- Tamoxifen (MeSH)